The First International HPV Vaccine Information Clearinghouse
Rasmussen Reports
Friday, August 20, 2010
Vaccinations are common requirements for children all over the country in order to attend public school and college. However, half of American adults (52%) say they are concerned about the safety of vaccinations for children, including 27% who are Very Concerned.
A new Rasmussen Reports telephone survey finds that 44% are not concerned about the safety of vaccines for children. But this includes just 13% who are Not At All Concerned.
Global revolt against deadly vaccines spreads as cases of debilitating illnesses, soft-kill side-effects and even instant deaths become widespread.
Paul Joseph Watson
Prison Planet.com
Monday, August 30, 2010
Cases of debilitating illnesses, soft-kill side-effects and even instant deaths as a result of vaccinations across the world are skyrocketing as the cover-up of deadly inoculations implodes and more people than ever become suspicious about what they are being injected with by health authorities who have proven they cannot be trusted.
The Lancet Infectious Diseases
Chris T Bauch
The Lancet Infectious Diseases, Volume 10, Issue 9, Page 595,
September 2010
doi:10.1016/S1473-3099(10)70183-3
Our Personal View1 presents a mathematical model to determine the conditions under which a decline in screening adherence in vaccinated women would outweigh the benefits of a human papillomvirus (HPV) immunisation programme, and thus result in a net increase in cervical cancer incidence. In their refutation, Diane Harper and colleagues’2 create a misrepresentation of our model and then refute that misrepresentation. First, Harper and colleagues interpret our model as showing that human papillomavirus (HPV) vaccination will prevent any future increase in incidence of cervical cancer. We find that such an increase is indeed possible, especially when screening coverage is high before vaccine introduction, however, it does not occur unless the decline in screening adherence is steep. Second, Harper and colleagues incorrectly cite the opportunistic screening scenario; for comparison to the situation in Finland, for which the organised screening scenario (high coverage) should be cited. Our model1 predicts that a rise in cervical cancer incidence in vaccinated women is more likely with organised screening than with opportunistic screening, and so data from Finland might actually validate our model.
Immunity 25, 179–184, August 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2006.08.002
Summary
An Australian newspaper recently bestowed Ian Frazerthe title of ‘‘God’s gift to women’’ for his research team’s part in developing a vaccine to help control cervical cancer. Here Frazer discusses this work and the science behind the vaccine.
Gardasil Unexplained Deaths.com
copyright
2010 Emily Tarsell, LCPC and James Garrett, PhD
February 18, 2010
Abstract
Background The Food and Drug Administration (FDA) concluded that the rates of Adverse Events Following Injections (AEFIs) for the human papillomavirus recombinant vaccine (qHPV) Gardasil were not greater than background rates. They also acknowledge limitations in the reporting system that could compromise this conclusion. On record as of 1/31/2010 were 15,829
AEFI reports including 49 deaths.
